Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?

MLA

Mok, Tony S. K., and Herbert H. Loong. “Are We Ready for Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer?” Lancet (London, England), vol. 387, no. 10027, Apr. 2016, pp. 1488–90. EBSCOhost, https://doi.org/10.1016/S0140-6736(15)01308-2.

APA

Mok, T. S. K., & Loong, H. H. (2016). Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer? Lancet (London, England), 387(10027), 1488–1490. https://doi.org/10.1016/S0140-6736(15)01308-2

Chicago

Mok, Tony S K, and Herbert H Loong. 2016. “Are We Ready for Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer?” Lancet (London, England) 387 (10027): 1488–90. doi:10.1016/S0140-6736(15)01308-2.